Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Imatinib

EU orphan designation number: EU/3/01/061
Active ingredient: Imatinib
Indication: Treatment of malignant gastrointestinal stromal tumours
Sponsor: Novartis Europharm Limited
One Canada Square, 34 Floor, Canary Wharf, London E14 5AB, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Glivec on 27/08/2001 with the number EU/1/01/198

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2001 Orphan Designation EMEA/OD/039/01 (2001)3576 of 20/11/2001
16/04/2012 Removal of orphan designation from Community Register